Recent Updates
Recently added Catalysts

Normal saline ,Control

Phase 3

Migraine Headache | Unknown | Neurology |The Cooper Companies, Inc.|Last Updated: Jul 15, 2019

Success Probability
Subscribe to view
Market & Valuation
Subscribe to view
Trial Design
UNCONTROLLED
Total Trials1
Total Enrollment50
FDA Designations
No designations recorded
Clinical trial landscape

Normal saline ,Control · 1 trial · 1 indication

Phase 2/3 1
NCT02933060Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine HeadacheMigraine Headache
COMPLETED50 Analytics
PHASE2/PHASE3COMPLETED
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
Migraine Headache
NCT0293306050
Unlock trial analytics
Study Design & Arms
Interventions
NameTypeDescription
Normal saline (1000 mL)OTHER -
ControlOTHER -
Unlock Study Design Details